Related to Investigators Use Synthetic DNA and Controlled Conjugation to Replace Every TAG Stop Codon in E. Coli

• Novartis Teams with Synthetic Genomics Vaccines to Develop Flu Seed Virus Banks
  
• Tate & Lyle to Manufacture Farnesene for Amyris
  
• Phase III Data Leads Intercell to Shelve Late-Stage Traveler’s Diarrhea Vaccine Patch
  
• Presidential Bioethics Commission Releases Review of Synthetic Biology
  
• Intrexon Makes $11.63M Equity Payment in Ziopharm as Part of DNA-Based Anticancer Drug Deal
  
• IAVI Partners with Indian Government Institute for Broad-Spectrum HIV Vaccine Initiative
  
• Researchers Create In Silico Model of E. coli Cell
  
• CellMed to Leverage Scarab Genomics’ Clean Genome E. coli Technology
  
• Intrexon Scores $100M to Bolster Synthetic Biology Operations
  
• Life Technologies Negotiates License to TAL Effector Gene Control Technology
  
• Researchers Combine Stem Cell with Artificial Chromosome to Treat Duchenne Muscular Dystrophy in Mice
  
• Selecta Wins SAIC Subcontract to Develop Synthetic Nanoparticle Malaria Vaccine
  
• Logic-Based Synthetic Gene Circuit Developed to Identify and Selectively Kill Cancer Cells
  
• SGI and IDT Pool Expertise to Offer Small Synthetic Gene Products
  
• Bellicum Raises $20M to Progress Cell Transplant and Cancer Vaccine Products
  
• GEN Poll Majority Favors Moratorium on Synthetic Bio Products
  
• GEN Poll Respondents Bullish on Synthetic Bio’s Potential for Solving Health, Environmental Problems
  
• Amyris Wins $8M from DARPA to Develop Synthetic Biology Tools, Processes
  
• Can DNA Be Downloaded?
  
• Scorecard Chides Administration on Synthetic Bio Policy Follow-Up